ZA200702656B - HIV inhibiting 5-substituted pyrimidines - Google Patents

HIV inhibiting 5-substituted pyrimidines

Info

Publication number
ZA200702656B
ZA200702656B ZA200702656A ZA200702656A ZA200702656B ZA 200702656 B ZA200702656 B ZA 200702656B ZA 200702656 A ZA200702656 A ZA 200702656A ZA 200702656 A ZA200702656 A ZA 200702656A ZA 200702656 B ZA200702656 B ZA 200702656B
Authority
ZA
South Africa
Prior art keywords
substituted pyrimidines
hiv inhibiting
hiv
inhibiting
pyrimidines
Prior art date
Application number
ZA200702656A
Other languages
English (en)
Inventor
Guillemont Jerome Emile Georges
Heeres Jan
Lewi Paulus Joannes
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200702656(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of ZA200702656B publication Critical patent/ZA200702656B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200702656A 2004-09-30 2007-03-29 HIV inhibiting 5-substituted pyrimidines ZA200702656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04104805 2004-09-30

Publications (1)

Publication Number Publication Date
ZA200702656B true ZA200702656B (en) 2008-08-27

Family

ID=34929637

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702656A ZA200702656B (en) 2004-09-30 2007-03-29 HIV inhibiting 5-substituted pyrimidines

Country Status (17)

Country Link
US (1) US8946248B2 (ja)
EP (1) EP1797047B1 (ja)
JP (1) JP5046943B2 (ja)
KR (1) KR20070057837A (ja)
CN (1) CN101027288B (ja)
AR (1) AR051315A1 (ja)
AT (1) ATE542802T1 (ja)
AU (1) AU2005288866B2 (ja)
BR (1) BRPI0516748B8 (ja)
CA (1) CA2575472C (ja)
ES (1) ES2380631T3 (ja)
IL (1) IL181056A (ja)
MX (1) MX2007003796A (ja)
RU (1) RU2410379C2 (ja)
TW (1) TW200626561A (ja)
WO (1) WO2006035069A1 (ja)
ZA (1) ZA200702656B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006035069A1 (en) 2004-09-30 2006-04-06 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-substituted pyrimidines
AU2005288864B2 (en) * 2004-09-30 2012-08-23 Janssen Sciences Ireland Uc HIV inhibiting 5-heterocyclyl pyrimidines
MX2007010051A (es) * 2005-02-18 2007-09-21 Tibotec Pharm Ltd Derivados de oxido de 2-(4-cianofenilamino)pirimidina que inhiben el virus de inmunodeficiencia humana.
ES2465666T3 (es) * 2006-03-30 2014-06-06 Janssen R&D Ireland Pirimidinas 5-amido-sustituidas inhibidoras del HIV
EP2114902B1 (en) * 2006-12-29 2014-09-17 Janssen R&D Ireland Hiv inhibiting 5,6-substituted pyrimidines
EP2114901B1 (en) * 2006-12-29 2014-04-09 Janssen R&D Ireland Hiv inhibiting 6-substituted pyrimidines
MX351754B (es) 2011-04-22 2017-10-27 Signal Pharm Llc Pirimidinas sustituidas de diaminocarboxamida y diaminocarbonitrilo, composiciones de las mismas y metodos de tratamiento con las mismas.
ES2664094T3 (es) * 2012-07-12 2018-04-18 Hetero Research Foundation Procedimiento de preparación de rilpivirina utilizando un intermedio nuevo
EA028052B1 (ru) * 2012-11-08 2017-10-31 Бристол-Майерс Сквибб Компани АЛКИЛАМИДЗАМЕЩЁННЫЕ ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ МОДУЛЯЦИИ IL-12, IL-23 И/ИЛИ IFNα
NZ715903A (en) 2014-01-30 2017-06-30 Signal Pharm Llc Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
US9796685B2 (en) 2014-12-16 2017-10-24 Signal Pharmaceuticals, Llc Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methylcyclohexylamino)-pyrimidine-5-carboxamide
WO2016100308A1 (en) 2014-12-16 2016-06-23 Signal Pharmaceuticals, Llc Methods for measurement of inhibition of c-jun n-terminal kinase in skin
CA2975260C (en) 2015-01-29 2024-05-21 Signal Pharmaceuticals Llc Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
AU2016297784B2 (en) 2015-07-24 2020-12-24 Celgene Corporation Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
EP0862463A1 (en) 1995-11-23 1998-09-09 Janssen Pharmaceutica N.V. Solid mixtures of cyclodextrins prepared via melt-extrusion
NO311614B1 (no) 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
ID26291A (id) 1998-03-27 2000-12-14 Janssen Pharmaceutica Nv Turunan-turunan pirimidina penghambat hiv
EP0945447A1 (en) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
OA11674A (en) 1998-11-10 2005-01-12 Janssen Pharmaceutica Nv HIV Replication inhibiting pyrimidines.
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
EP1282606B1 (en) * 2000-05-08 2015-04-22 Janssen Pharmaceutica NV Hiv replication inhibiting pyrimidines and triazines
KR100947185B1 (ko) 2000-12-21 2010-03-15 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로서 유용한 피라졸 화합물 및 이를 포함하는 조성물
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
AP1927A (en) 2002-11-15 2008-12-10 Tibotec Pharm Ltd Substituted indolepyridinium as anti-infective compounds
US7504396B2 (en) 2003-06-24 2009-03-17 Amgen Inc. Substituted heterocyclic compounds and methods of use
WO2006035069A1 (en) 2004-09-30 2006-04-06 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-substituted pyrimidines
AU2005288864B2 (en) 2004-09-30 2012-08-23 Janssen Sciences Ireland Uc HIV inhibiting 5-heterocyclyl pyrimidines
KR20070057798A (ko) 2004-09-30 2007-06-07 티보텍 파마슈티칼즈 리미티드 Ｈｉｖ를 저해하는 5-탄소환 또는 복소환으로 치환된피리미딘
ES2465666T3 (es) 2006-03-30 2014-06-06 Janssen R&D Ireland Pirimidinas 5-amido-sustituidas inhibidoras del HIV
EP2114901B1 (en) 2006-12-29 2014-04-09 Janssen R&D Ireland Hiv inhibiting 6-substituted pyrimidines
EP2114902B1 (en) 2006-12-29 2014-09-17 Janssen R&D Ireland Hiv inhibiting 5,6-substituted pyrimidines

Also Published As

Publication number Publication date
BRPI0516748A (pt) 2008-09-23
US8946248B2 (en) 2015-02-03
CN101027288B (zh) 2013-04-17
CA2575472A1 (en) 2006-04-06
TW200626561A (en) 2006-08-01
JP5046943B2 (ja) 2012-10-10
RU2410379C2 (ru) 2011-01-27
AU2005288866B2 (en) 2012-07-26
WO2006035069A1 (en) 2006-04-06
ES2380631T3 (es) 2012-05-17
AR051315A1 (es) 2007-01-03
US20080262007A1 (en) 2008-10-23
MX2007003796A (es) 2007-04-25
CN101027288A (zh) 2007-08-29
CA2575472C (en) 2013-07-30
ATE542802T1 (de) 2012-02-15
IL181056A0 (en) 2007-07-04
KR20070057837A (ko) 2007-06-07
EP1797047B1 (en) 2012-01-25
JP2008514681A (ja) 2008-05-08
IL181056A (en) 2014-02-27
AU2005288866A1 (en) 2006-04-06
BRPI0516748B1 (pt) 2019-11-19
BRPI0516748B8 (pt) 2021-05-25
RU2007116172A (ru) 2008-11-10
EP1797047A1 (en) 2007-06-20

Similar Documents

Publication Publication Date Title
IL180959A0 (en) Hiv inhibiting 5-heterocyclyl pyrimidines
IL181056A0 (en) Hiv inhibiting 5-substituted pyrimidines
ZA200702655B (en) HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines
ZA200703444B (en) HIV inhibiting bicyclic pyrimidine derivatives
EG24843A (en) Herbicidal pyrimidines
IL181433A0 (en) Pyrimidine derivatives
IL193610A0 (en) Hiv inhibiting 5-amido substituted pyrimidines
IL181386A0 (en) Pyrimidine derivatives
EP1724267A4 (en) PYRIMIDINE DERIVATIVE
HK1121062A1 (en) Pyrimidine compounds
IL181219A0 (en) Heterocyclic antiviral compounds
IL179534A0 (en) Heterocyclic antiviral compounds
IL179914A0 (en) Pyrimidine derivatives
AP2007004040A0 (en) Pyridazinone compounds
GB0415364D0 (en) Pyrimidine derivatives
EP1747329A4 (en) DESIGN ELEMENTS
DE502005003298D1 (en) Ls
GB0415367D0 (en) Pyrimidine derivatives
PL1644343T3 (pl) Pochodne 5-podstawionego chinazolinonu
GB0405985D0 (en) Kinase
EP1816701A4 (en) PASSIVE PART
EP1906132A4 (de) Pistolentasche
GB0415887D0 (en) Range finder
GB0424972D0 (en) Pyrimidine compounds
GB0403661D0 (en) Soldier